New in vitro model to study high glucose-dependent endothelial dysfunctions

Biochimie

Volumn 85, Issue 7, 2003, Pages 701-705

  Donnini, Debora ^a   Del Terra, Elisa ^a   Ambesi Impiombato, Francesco Saverio ^a   Curcio, Francesco ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Atherosclerosis; Endothelial cell culture; Hyperglycemia

Indexed keywords

GLUCOSE; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

AORTA; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL ISOLATION; CELL STRAIN; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIUM INJURY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERGLYCEMIA; IN VITRO STUDY; LEUKOCYTE; PATHOPHYSIOLOGY; THROMBOCYTE; THROMBOCYTE ANOMALY; THROMBOSIS; VASCULAR DISEASE;

EID: 0141990748     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(03)00116-0     Document Type: Article

References (18)

1. N. Ruderman, J. Williamson, M. Brownlee, Glucose and diabetic vascular disease, FASEB J 6 (1992) 2905-2914.
2. A.C. Sharma, B.G. Fogelson, S.I. Nawas, W.T. Vigneswaran, A.D. Sam II, K.J. Alden, J.L. Ferguson, W.R. Law, Elevated coronary endothelin-1 but not nitric oxide in diabetics during CABG, Ann. Thorac. Surg. 67 (1999) 1659-1663.
3. W.G. Mayhan, S.D. Irvine, G.M Sharpe, Constrictor response of resistance arterioles during diabetes mellitus, Diabetes Res. Clin. Pract. 44 (1999) 147-156.
4. R.A. Cohen, The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease, Prog. Cardiovasc. Dis. 38 (1995) 105-128.
5. P. Galajada, E. Martinka, P. Kubisz, M. Mokan, Tissue plasminogen activator and diabetes mellitus, Vnitr. Lek. 44 (1998) 661-664.
6. A. Geppert, S. Graft, R. Beckmann, S. Hornykewycz, E. Schuster, B.R. Binder, K. Huber, Concentration of endogenous tPA antigen in coronary artery disease: Relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease, Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1634-1642.
7. D. Donnini, G. Perrella, G. Stel, F.S. Ambesi-Impiombato, F. Curcio, A new model of human aortic endothelial cells in vitro, Biochimie 82 (2000) 1-8.
8. D. Donnini, F. Ciarfaglia, S. Zamparo, G. Stel, F. Curcio, Characterization of two different cell strains from human aortic endothelium, Thromb. Haemostasis August (Suppl) (1999) 814.
9. F. Curcio, F.S. Ambesi-Impiombato, G. Perrella, H.G. Coon, Long-term culture and functional characterization of follicular cells from adult normal human thyroids, Proc. Natl. Acad. Sci. USA 91 (1994) 9004-9008.
10. D.V. Parums, J.L. Cordell, K. Micklem, A.R. Heryet, K.C. Gatter, D.Y. Manson, JC 70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections, J. Clin. Pathol. 43 (1990) 752-757.
11. M. Lorenzi, E. Cagliero, S. Toledo, Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cucle, and accellerated death, Diabetes 34 (1985) 621-627.
12. F. Curcio, A. Ceriello, Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: New insights on the pathophysiological mechanisms of diabetic vascular complications, In Vitro Cell Dev. Biol. 28 (1992) 787-790.
13. A.M. Thogersen, J.H. Jansson, K. Boman, T.K. Nilsson, L. Weinehall, F. Huhtasaari, G. Hallmans, High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor, Circulation 24 (1998) 2241-2247.
14. P. Galajda, E. Martinka, D. Balaz, J. Stasko, J. Kerny, E. Plankova, M. Mokan, P. Kubisz, Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus, Vnitr. Lek. 43 (1997) 744-747.
15. A.J. Simpson, N.A. Booth, N.R. Moore, S.J. Lewis, R.S. Gray, Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: A pilot study, Acta Diabetol. 36 (1999) 155-158.
16. W.L. Chandler, M.C. Alessi, M.F. Aillaud, P. Henderson, P. Vague, I. Juhan-Vague, Clearance of tissue plasminogen activator (tPA) and tPA/plasminogen activator inhibitor type 1 (PAI-1) complex: Relationship to elevated tPA antigen in patients with high PAI-1 activity levels, Circulation 96 (1997) 761-768.
17. R. Bucala, K.J. Tracey, A. Cerami, Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes, J. Clin. Invest. 87 (1992) 432-438.
18. M. Kakoki, Y. Hirata, H. Hayakawa, A. Tojo, D. Nagata, E. Suzuki, K. Kimura, A. Goto, K. Kikuchi, T. Nagano, M. Omata, Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelial type B receptor-mediated nitric oxide release from rat kidney, Circulation 99 (1999) 1242-1248.